Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Aradigm Corp (ARDM)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Latest Headlines for [[ item.sessionDateDisplayLong ]]
SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Aradigm Corporation (ARDM) & Lead Plaintiff Deadline: March 12, 2018

Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Aradigm Corporation ("Aradigm" or the "Company") (NASDAQ:ARDM) and certain...

ARDM : 2.06 (-8.85%)
INVESTOR ALERT: Holzer & Holzer Announces Class Action Lawsuit Filed on Behalf of Investors in Aradigm

Holzer & Holzer, LLC announces that a class action lawsuit has been filed on behalf of investors who purchased Aradigm Corporation ("Aradigm" or the "Company") (NASDAQ: ARDM) securities between...

ARDM : 2.06 (-8.85%)
INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Investors of an Investigation Involving Possible Securities Fraud Violations by the Board of Directors of Aradigm Corporation

Levi & Korsinsky announces it has commenced an investigation of Aradigm Corporation (NASDAQCM:ARDM) concerning possible violations of federal securities laws.

ARDM : 2.06 (-8.85%)
Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Aradigm Corporation (ARDM)

Gainey McKenna & Egleston announces that a class action lawsuit has been filed against Aradigm Corporation ("Aradigm" or the "Company") (NASDAQ:ARDM) in the United States District Court for the Northern...

ARDM : 2.06 (-8.85%)
ARADIGM INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Aradigm Corporation To Contact The Firm

NEW YORK, NY / ACCESSWIRE / January 12, 2018 / Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Aradigm Corporation ("Aradigm" or the "Company") (NASDAQ:...

ARDM : 2.06 (-8.85%)
EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Aradigm Corporation

Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Aradigm Corporation (NASDAQ: ARDM) from July...

ARDM : 2.06 (-8.85%)
Aradigm's Bronchiectasis Candidate Has Negative FDA Vote

The FDA panel votes against the approval of Aradigm's (ARDM) Linhaliq for treatment of non-cystic fibrosis bronchiectasis. A response from the regulatory agency is expected on Jan 26, 2018.

XOMA : 31.56 (-6.38%)
ARDM : 2.06 (-8.85%)
SCMP : 18.05 (unch)
EXEL : 29.65 (-2.40%)
SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Aradigm Corporation (ARDM) & Lead Plaintiff Deadline: March 12, 2018

Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Aradigm Corporation ("Aradigm" or the "Company") (NASDAQ: ARDM) and certain...

ARDM : 2.06 (-8.85%)
SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Aradigm Corporation (ARDM) & Lead Plaintiff Deadline: March 12, 2018

NEW YORK , Jan. 12, 2018 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Aradigm Corporation ("Aradigm"...

ARDM : 2.06 (-8.85%)
Pomerantz Law Firm Announces the Filing of a Class Action against Aradigm Corporation and Certain Officers - ARDM

Pomerantz LLP announces that a class action lawsuit has been filed against Aradigm Corporation ("Aradigm" or the "Company") (NASDAQ:ARDM) and certain of its officers. The class action, filed in United...

ARDM : 2.06 (-8.85%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Aradigm Corporation - ARDM

NEW YORK , Jan. 10, 2018 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Aradigm Corporation ("Aradigm" or the "Company") (NASDAQ: ARDM).   Such investors are advised...

ARDM : 2.06 (-8.85%)
ARADIGM INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Aradigm Corporation To Contact The Firm

Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Aradigm Corporation ("Aradigm" or the "Company") (NASDAQ: ARDM).

ARDM : 2.06 (-8.85%)
ARADIGM INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Aradigm Corporation To Contact The Firm

NEW YORK , Jan. 10, 2018 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Aradigm Corporation ("Aradigm" or the "Company")...

ARDM : 2.06 (-8.85%)
EQUITY ALERT: Rosen Law Firm Announces Investigation of Securities Claims Against Aradigm Corporation - ARDM

Rosen Law Firm, a global investor rights law firm, announces it is investigating potential securities claims on behalf of purchasers of the securities of Aradigm Corporation (NASDAQ:ARDM)...

ARDM : 2.06 (-8.85%)
SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Aradigm Corporation (ARDM)

Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Aradigm Corporation ("Aradigm" or the "Company") (NASDAQ: ARDM). Such investors are...

ARDM : 2.06 (-8.85%)
The Zacks Analyst Blog Highlights: Synergy Pharmaceuticals, Aradigm and Sucampo Pharmaceuticals

The Zacks Analyst Blog Highlights: Synergy Pharmaceuticals, Aradigm and Sucampo Pharmaceuticals

ARDM : 2.06 (-8.85%)
SCMP : 18.05 (unch)
SGYP : 2.24 (-6.28%)
3 Biotech and Pharma Stocks with FDA Catalysts this January

2017 saw the FDA approving 46 novel drugs as well as path-breaking treatments like Novartis's (NVS) Kymriah and Gilead's Yescarta. Here is a look at three companies expecting a decision this January.

ARDM : 2.06 (-8.85%)
SCMP : 18.05 (unch)
NVS : 86.73 (+0.09%)
GILD : 80.25 (+1.56%)
RHHBY : 30.6800 (-3.45%)
SGYP : 2.24 (-6.28%)
SNY : 44.91 (+0.29%)
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of Aradigm Corporation

Levi & Korsinsky announces it has commenced an investigation of Aradigm Corporation (NASDAQ: ARDM) concerning possible breaches of fiduciary duty. To obtain additional information, go to:...

ARDM : 2.06 (-8.85%)
Quotidian Technical Highlights on Selected Healthcare Stocks -- Quidel, PetMed Express, Valeant Pharma, and Aradigm

In keeping with the commitment to dynamically provide members with timely information, WallStEquities.com has issued free tailored Stock Review on QDEL, PETS, VRX, and ARDM which is a click away at http://www.wallstequities.com/registration....

VRX.TO : 28.60 (-5.64%)
PETS : 51.78 (-2.19%)
ARDM : 2.06 (-8.85%)
VRX : 22.98 (-3.61%)
QDEL : 46.41 (+0.91%)
Aradigm Announces FDA Advisory Committee Meeting for Linhaliq

Aradigm Corporation (NASDAQ: ARDM) (the "Company") today announced that a meeting of the Antimicrobial Drugs Advisory Committee of the U.S. Food and Drug Administration (FDA) has been scheduled...

ARDM : 2.06 (-8.85%)

Van Meerten Stock Picks

My 5 Favorite Mid Cap Stocks
This morning I wanted to find 5 Mid Cap stocks that had great returns over the past year and still seem to have some juice left.
KBH -1.63 , IPGP +2.02 , FSLR -2.19 , NVR -17.23 , SGMS +0.25
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.

Barchart Morning Call

OVERNIGHT MARKETS AND NEWS Mar E-mini S&Ps ( ESH18 +0.39%) are up +0.41% at a fresh record nearest-futures high as growth optimism fuels gains in global equity markets. Gains in technology stocks are leading the overall market higher as... Read More

Chart of the Day

Chart of the Day

Audentes Therapeutcs (BOLD) is rhe Barchart Chart of the Day.  The biomedical company has a Trend Spotter buy signal, a Weighted Alpha of 174.58+ and gained 111.74% in the last year.
Read More

Brugler Ag Report

Today's Commentary

Corn futures bounced back from Friday’s bearish USDA reports to close Tuesday with gains of 2 cents in most nearby contracts. The weekly Export Inspections report indicated just 584,389 MT of corn was shipped during the week of Jan 11. That is ...
Read More

Alan Brugler writes this daily agricultural markets overview with opening, midday and closing comments directed at the gain and meat Ag markets.

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.